Company Releases First Product: Generative AI-Powered Staffing Marketplace for Healthcare and will use Funds to Accelerate Further Product Development and Conduct Phase Three Safety Testing for its LLM

该公司发布了第一个产品：基于人工智能的医疗保健人员配置市场，并将利用资金加速进一步的产品开发，并为其LLM进行第三阶段安全测试

Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced the close of a $53 million Series A funding round at a $500 million valuation, bringing total funding to $120 million. Today, the company also released its first product for phase three safety testing: a staffing marketplace for healthcare where health systems, payors, and others can “hire” generative AI agents that complete low-risk, non-diagnostic, patient-facing healthcare tasks to help solve the massive shortage of healthcare nurses, social workers, and nutritionists in the US and worldwide.

希波克拉底人工智能公司（Hippocratic AI）是第一家为医疗保健建立以安全为中心的大型语言模型（LLM）的公司，今天宣布以5亿美元的估值结束一轮5300万美元的a系列融资，使总资金达到1.2亿美元。今天，该公司还发布了第一个用于第三阶段安全测试的产品：医疗保健人员市场，卫生系统，付款人和其他人可以“雇用”生成性人工智能代理，完成低风险，非诊断性，面向患者的医疗保健任务，以帮助解决美国和全球医疗保健护士，社会工作者和营养学家的巨大短缺。

The new capital will be used to help fund these safety tests and further develop the product..

新资金将用于资助这些安全测试并进一步开发产品。

The round was co-led by Premji Invest and General Catalyst with participation from SV Angel and Memorial Hermann Health System as well as existing investors Andreessen Horowitz (a16z) Bio + Health, Cincinnati Children’s, WellSpan Health, and Universal Health Services (UHS).

这一轮由Premji Invest和General Catalyst共同领导，SV Angel和Memorial Hermann Health System以及现有投资者Andreessen Horowitz（a16z）Bio+Health，辛辛那提儿童，WellSpan Health和全民健康服务（UHS）参与。

The company was founded on the belief that Generative AI holds the potential to improve healthcare access, equity, and outcomes but that it has to be developed and deployed safely and responsibly. The round was significantly oversubscribed, allowing the company to select lead investors who were patient enough to allow the company to prioritize safety over short-term revenue and profits..

该公司的成立是基于这样的信念，即生成性人工智能具有改善医疗服务获取，公平和结果的潜力，但它必须安全和负责任地开发和部署。这轮交易被大量超额认购，使得该公司能够选择足够耐心的主要投资者，使该公司能够将安全优先于短期收入和利润。

“Premji Invest supports the Azim Premji Foundation’s non-profit activities in perpetuity by investing in companies that can create long-term societal value. The Foundation runs deep, on-the-ground work in healthcare and education,” said Sandesh Patnam, Managing Partner at Premji Invest. “Hippocratic AI’s approach towards safe AI helps further the Foundation’s mission.

Premji Invest管理合伙人Sandesh Patnam表示：“Premji Invest通过投资能够创造长期社会价值的公司，永久支持Azim Premji基金会的非营利活动。该基金会在医疗保健和教育领域开展深入的基础工作。”。“希波克拉底人工智能（Hippocratic AI）实现安全人工智能的方法有助于推进基金会的使命。

The team has the potential to transform healthcare with an LLM that is safe and effective. We look forward to working with this ambitious and talented team to achieve better outcomes for patients around the globe.”.

该团队有潜力通过安全有效的LLM改变医疗保健。我们期待着与这个雄心勃勃、才华横溢的团队合作，为全球患者取得更好的结果。”

“Since the founding of Hippocratic AI a year ago, the company trained its foundational model, achieved a key safety threshold, identified novel use cases to solve the healthcare staffing crisis, and established partnerships with 40 health systems, payors, and digital health companies,” said Hemant Taneja, CEO and Managing Director at General Catalyst.

General Catalyst首席执行官兼董事总经理赫曼特·塔内贾（Hemant Taneja）表示：“自一年前希波克拉底人工智能（Hippocratic AI）成立以来，该公司训练了其基础模型，达到了关键的安全门槛，确定了解决医疗保健人员配置危机的新用例，并与40家医疗系统、支付机构和数字健康公司建立了合作关系。”

“Hippocratic AI has grown rapidly due to sound execution and strategy while prioritizing safety. The company is a leading standard of radical collaboration at work and will play a critical role in transforming our healthcare system to make it more proactive, affordable, and equitable.”.

“希波克拉底人工智能（Hippocratic AI）凭借良好的执行力和战略迅速发展，同时将安全置于首位。该公司是工作中激进合作的领先标准，将在改变我们的医疗体系方面发挥关键作用，使其更具前瞻性、经济性和公平性。”

Today the company begins the next stage of its responsible AI journey by releasing its first product for phase three safety testing. The company has pioneered a clinician-driven safety testing system for LLMs. Phase one testing was conducted by leading physicians and nurses (< 50) to ensure the agent completes all critical checklist items with the patient for a given use case.

今天，该公司发布了第一款用于第三阶段安全测试的产品，开始了负责任的人工智能旅程的下一阶段。该公司开创了一种由临床医生驱动的LLM安全测试系统。第一阶段测试由主要医生和护士（<50）进行，以确保代理人完成给定用例中患者的所有关键检查表项目。

Phase two testing required testing to be completed by 1000+ licensed US nurses, and 100+ US licensed physicians talking to the AI while acting as a patient. Phase three testing, which begins now, requires the testing to be completed by 5,000 licensed nurses, 500 licensed physicians, and the company’s health system partners..

第二阶段测试要求1000多名美国注册护士和100多名美国注册医生在作为患者时与AI交谈。第三阶段测试现在开始，要求5000名持照护士、500名持照医生和公司的卫生系统合作伙伴完成测试。

The product is a novel staffing marketplace where health systems, payors, and others can “hire” auto-pilot generative AI-powered agents to conduct low-risk, non-diagnostic, patient-facing services to help solve the massive healthcare staffing crisis. This marketplace is part of the company’s vision around how generative AI can provide super staffing and healthcare abundance and equity for the first time in history.

该产品是一个新颖的人员配置市场，卫生系统，付款人和其他人可以“雇用”自动试点生成人工智能代理，以执行低风险，非诊断，面向患者的服务，以帮助解决大规模的医疗保健人员配置危机。这一市场是该公司愿景的一部分，该愿景围绕着生成性人工智能如何在历史上首次提供超级人员配置、医疗保健丰富性和公平性。

Initial roles include chronic care management, post-discharge follow-up for specific conditions such as congestive heart failure and kidney disease, as well as wellness and social determinants of health surveys, health risk assessments, and pre-operative outreach. However, these agents won’t be allowed to speak with patients unsupervised until phase three of the safety testing is completed..

最初的角色包括慢性护理管理，针对充血性心力衰竭和肾脏疾病等特定疾病的出院后随访，以及健康调查，健康风险评估和术前外展的健康和社会决定因素。然而，在安全测试的第三阶段完成之前，这些代理人不允许在无人监督的情况下与患者交谈。

The company decided to move to phase three testing because of the promising results of phase one and two testing. In these earlier phases, 1002 US licensed nurses and 130 US licensed physicians were asked to act as patients and speak to the company’s agents in a variety of use cases. After each encounter, they were asked to assess the product on subjective and objective safety measures and compare the product to real nurses and other LLMs such as GPT4 and LLaMA 2 70B Chat.

该公司决定进入第三阶段测试，因为第一阶段和第二阶段测试的结果令人鼓舞。在这些早期阶段，1002名美国注册护士和130名美国注册医生被要求担任患者，并在各种用例中与公司代理人交谈。每次见面后，他们都被要求评估产品的主观和客观安全措施，并将产品与真正的护士和其他LLM（如GPT4和LLaMA 2 70B Chat）进行比较。

The results of these studies are presented in a paper released today called Polaris: A Safety-focused LLM Constellation Architecture for Healthcare. Some highlights of the paper include:.

这些研究的结果发表在今天发布的一篇名为Polaris的论文中：一种以安全为中心的LLM星座医疗保健体系结构。本文的一些亮点包括：

These successful benchmarks are the result of Hippocratic AI’s unique three-part approach to safety, comprised of: (1) a 70B-100B primary model trained using evidence-based content, (2) a novel constellation architecture with multiple models totaling over one trillion parameters, in which the primary LLM is supervised by multiple specialist support models to improve medical accuracy and substantially reduce hallucinations (more on this architecture in Hippocratic’s paper), and (3) built-in guardrails that bring in a human supervisor when necessary..

这些成功的基准是希波克拉底人工智能独特的三部分安全方法的结果，包括：（1）使用循证内容训练的70B-100B主要模型，（2）具有多个模型的新型星座架构，总计超过一万亿个参数，其中主要LLM由多个专家支持模型监督，以提高医疗准确性并大大减少幻觉（希波克拉底的论文中对此架构进行了更多介绍），以及（3）内置护栏，必要时可引入人类监督员。

In addition, product development is guided by several Hippocratic AI oversight groups, including a safety governance council, a Physician Advisory Council, and a Nurse Advisory Council, which bring together esteemed physicians and registered nurses hailing from leading health systems and digital health companies such as Cleveland Clinic, Nicklaus Children’s Hospital, Teladoc Health, WebMD, Massachusetts General Hospital, University of Illinois Health System, and more..

此外，产品开发由几个希波克拉底人工智能监督小组指导，包括安全管理委员会、医生咨询委员会和护士咨询委员会，这些小组汇集了来自克利夫兰诊所、尼克劳斯儿童医院、Teladoc health、WebMD、马萨诸塞州总医院、伊利诺伊大学卫生系统等领先卫生系统和数字健康公司的尊敬的医生和注册护士。

For phase three testing, Hippocratic AI will ask its 40+ partners to thoroughly test the safety of this novel Generative AI-based product. These partners include HonorHealth, Cincinnati Children’s, OhioHealth, Roper St. Francis Healthcare, Universal Health Services, ELNA, SonderMind, Vital Software, Capsule, Evernow, HarmonyCares, Guidehealth, University of Vermont Health Network, Memorial Hermann Health System, Fraser Health, Side Health, and many more.

对于第三阶段测试，希波克拉底人工智能将要求其40多个合作伙伴彻底测试这种新型生成人工智能产品的安全性。这些合作伙伴包括HonorHealth、辛辛那提儿童、OhioHealth、Roper St.Francis Healthcare、Universal Health Services、ELNA、SonderMind、Vital Software、Capsule、Evernow、HarmonyCares、Guidehealth、佛蒙特大学健康网络、Memorial Hermann Health System、Fraser Health、Side Health等。

In addition to these partners, the company will significantly expand testing with more licensed nurses and physicians..

除了这些合作伙伴之外，该公司还将与更多持牌护士和医生一起大幅扩大测试范围。

“When we started the company, we prioritized safety as our top value. This is why we named the company after the physician’s Hippocratic Oath and made the tagline ‘Do no harm,’” said Munjal Shah, Co-Founder and CEO at Hippocratic AI. “This has been our guiding principle since the company’s founding.

希波克拉底AI联合创始人兼首席执行官穆哈尔·沙阿（Munjal Shah）表示：“当我们成立公司时，我们将安全作为最高价值。这就是为什么我们以医生的希波克拉底誓言命名公司，并以“无害”为口号。这是我们自公司成立以来的指导原则。

Our focus on safety testing our product in multiple phases and transparent publication of the results for everyone to see is the next down payment in this safety-first journey. Our selection of partners who align with our values and have the patience to let us pursue safety over revenue and profits further underscores our commitment to these values.”.

我们专注于在多个阶段对产品进行安全测试，并将结果透明发布给每个人，这是安全第一旅程的下一笔预付款。我们选择的合作伙伴符合我们的价值观，并有耐心让我们追求安全而不是收入和利润，这进一步突显了我们对这些价值观的承诺。”

To learn more about Hippocratic AI and the company’s first products, visit hippocraticai.com.

要了解更多关于希波克拉底人工智能和公司的首批产品，请访问hippocraticai.com。

About Hippocratic AI

关于希波克拉底AI

Hippocratic AI’s mission is to develop the first safest focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health.

希波克拉底人工智能（Hippocratic AI）的使命是为医疗保健开发第一个最安全的大型语言模型（LLM）。该公司相信，安全的LLM可以通过为每个人带来深入的医疗保健专业知识，极大地改善世界各地的医疗保健可及性和健康结果。没有其他技术有可能对健康产生如此程度的全球影响。

The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and Nvidia. Hippocratic AI has received a total of $120M in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, and SV Angel.

该公司由首席执行官Munjal Shah与El Camino Health、约翰·霍普金斯大学、圣路易斯华盛顿大学、斯坦福大学、谷歌和Nvidia的一群医生、医院管理人员、医疗保健专业人员和人工智能研究人员共同创立。希波克拉底人工智能（Hippocratic AI）已获得总计1.2亿美元的资金，并得到了主要投资者的支持，包括General Catalyst、Andreessen Horowitz、Premji Invest和SV Angel。

For more information on Hippocratic AI hippocraticai.com..

有关希波克拉底AI的更多信息，请访问希波克拉底网站。

About General Catalyst

关于General Catalyst

General Catalyst is a venture capital firm that invests in powerful, positive change that endures — for our entrepreneurs, our investors, our people, and society. We support founders with a long-term view who challenge the status quo, partnering with them from seed to growth stage and beyond to build companies that withstand the test of time.

General Catalyst是一家风险投资公司，致力于为我们的企业家、投资者、人民和社会带来持久而有力的积极变化。我们以长远的眼光支持那些挑战现状的创始人，与他们从种子期到成长期甚至更远的时期合作，打造经得起时间考验的公司。

With offices in San Francisco, Palo Alto, New York City, London, Berlin, and Boston, the firm has helped support the growth of businesses such as Airbnb, Deliveroo, Guild, Gusto, Hubspot, Illumio, Lemonade, Livongo, Oscar, Samsara, Snap, Stripe, and Warby Parker. For more generalcatalyst.com..

该公司在旧金山、帕洛阿尔托、纽约、伦敦、柏林和波士顿设有办事处，帮助支持了Airbnb、Deliverio、Guild、Gusto、Hubspot、Illumio、Lemonade、Livongo、Oscar、轮回、Snap、Stripe和Warby Parker等业务的发展。了解更多generalcatalyst.com。

About Premji Invest

关于Premji Invest

Premji Invest’s evergreen capital structure allows us to be long-term partners from inception to IPO and beyond. Our investment strategy spans the entire lifecycle of a company, starting from Series A funding rounds all the way to the pre-IPO stage in the private market. Additionally, we extend our focus into the public markets, employing a long-term, fundamental approach to investing.

Premji Invest的常青资本结构使我们能够从成立到首次公开募股（IPO）以及以后成为长期合作伙伴。我们的投资战略跨越了公司的整个生命周期，从a轮融资到私人市场的上市前阶段。此外，我们将重点扩展到公共市场，采用长期的基本投资方法。

Our multi-stage approach allows us to glean insights from successful ‘at scale’ companies, providing long-term strategic guidance to emerging enterprises. We hope to partner with courageous founders, being involved in all aspects of company building including talent acquisition, business development, investor syndicate building, and access to downstream capital.

我们的多阶段方法使我们能够从成功的“规模”公司中收集见解，为新兴企业提供长期战略指导。我们希望与勇敢的创始人合作，参与公司建设的各个方面，包括人才收购、业务发展、投资者财团建设以及获得下游资本。

Our previous investments include Anaplan, Coupa, Zuora, Apttus, Looker, Servicemax, Ikigai Labs, Holistic AI, Devoted Health, Included Health, and Firefly. For more premjiinvest.com..

我们之前的投资包括Anaplan、Coupa、Zuora、Apttus、Looker、Servicemax、Ikigai Labs、整体人工智能、专注健康、Included Health和Firefly。欲了解更多premjiinvest.com。